Haisco Pharmaceutical Group Co., Ltd.
Works in Dermatology · GI & liver · Hematology · Immunology · Metabolic & endocrine · Neurology · Oncology · Renal & urogenital · Respiratory · Women's health
Haisco Pharmaceutical Group Co., Ltd. is a clinical trial sponsor. It has 48 active clinical trials with 10,643 planned participants, across 10 therapeutic areas. Since 2021 it has completed 57 trials and stopped 0 early.
Trial track record · since 2021
Pipeline · 48 active trials
| Stage | Trial | Status |
|---|---|---|
On the market
1 approved drug application with a product on the market.
Questions about Haisco Pharmaceutical Group Co., Ltd
Haisco Pharmaceutical Group Co., Ltd is lead sponsor of 48 active clinical trials on ClinicalTrials.gov, with 10,643 planned participants, in Dermatology, GI & liver, Hematology, Immunology and other areas. Since 2021 it has completed 57 trials and stopped 0 early.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with Haisco Pharmaceutical Group Co., Ltd; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-09-29.
Approve Suite is not affiliated with Haisco Pharmaceutical Group Co., Ltd..
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.